1[1]Gulliver T,Morton R,Eid N.Inhaled corticosteroids in children with asthma:pharmacologic determinants of safety and efficacy and other clinical considerations.Paediatr Drugs,2007,9(3):185-194. 被引量：1
2[2]Sobande PO,Kercsmar CM.Inhaled corticosteroids in asthma management.Respir Care,2008,53(5):625-634. 被引量：1
3[3]Dahl R.Ciclesonide for the treatment of asthma.Ther Clin Risk Manag,2006,2(1):25-38. 被引量：1
4[4]Bisgaard H.Leukotriene modifiers in pediatric asthma management.Pediatrics,2001,107(2):381-390. 被引量：1
5[5]Barnes NC,De Jong B,Miyamoto T.Worldwide clinical experience with the first marketed leukotriene receptor antagonist.Chest,1997,111(2):52-60. 被引量：1
6[6]Donohue JF.Safety and efficacy of Beta agonists.Respir Care,2008,53(5):618-624. 被引量：1
7[7]Humbert M,Garcia G,Chanez P.Targeted immunologic therapies for severe asthma.Presse Med,2008,37(1 Pt 2):173-181.Epub 2007 Nov 5. 被引量：1
8[8]Morokata T,Ida K,Yamada T.CharacterizatiOn 0f YM一90709 as a novel antagonist which inhibits the binding of interleukin一5 to interleukin一5 receptor.Int Immunopharmacol,2002,2(12):1693-1702. 被引量：1
